Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 CAD | 0.00% |
|
-28.57% | -54.55% |
06-07 | Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD | CI |
05-31 | Transcript : Numinus Wellness Inc. - Shareholder/Analyst Call |